Myles Minter
Stock Analyst at William Blair
(0.84)
# 3,803
Out of 4,883 analysts
22
Total ratings
47.06%
Success rate
-13.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $18.17 | - | 1 | Jul 2, 2025 | |
| VERV Verve Therapeutics | Downgrades: Market Perform | n/a | $11.16 | - | 1 | Jun 17, 2025 | |
| VIGL Vigil Neuroscience | Downgrades: Market Perform | n/a | $7.99 | - | 1 | May 22, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $0.77 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $1.40 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $546.04 | - | 2 | Nov 1, 2024 | |
| KRRO Korro Bio | Initiates: Outperform | n/a | $12.58 | - | 1 | Aug 14, 2024 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $0.90 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $13.36 | +431.44% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $29.90 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $459.41 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $46.68 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $3.20 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $324.13 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $41.78 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.44 | - | 1 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $127.88 | -9.29% | 1 | Feb 24, 2020 |
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $18.17
Upside: -
Verve Therapeutics
Jun 17, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $11.16
Upside: -
Vigil Neuroscience
May 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $7.99
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.77
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.40
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $546.04
Upside: -
Korro Bio
Aug 14, 2024
Initiates: Outperform
Price Target: n/a
Current: $12.58
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.90
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $13.36
Upside: +431.44%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $29.90
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $459.41
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $46.68
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $3.20
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $324.13
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $41.78
Upside: -
Sep 27, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.44
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $127.88
Upside: -9.29%